MSCP HOLDINGS LIMITED
Get an alert when MSCP HOLDINGS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-09-21 (in 4mo)
Last made up 2025-09-07
Watchouts
Cash
—
Latest balance sheet
Net assets
£89K
-52.5% vs 2023
Employees
—
Average over period
Profit before tax
-£98K
-13.9% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
At the time of approving the financial statements, the directors considered the financial position of the Company as a non trading entity and their accompanying risks, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future, being at least 12 months from the approval of the Annual report and financial statements, however, the Company is in a net current liability position of £1,331,319 as at 31 December 2024, primarily consisting of amounts owed to the group undertakings. The directors understand that Nuffield Health will not demand repayment of the £1,330,879 balance due to group undertakings. However, the directors have not received a binding commitment that this support will be forthcoming in the future. Nevertheless the directors are of the view that the ultimate controlling parent undertaking will ensure that sufficient funds are available to settle any liabilities when they fall due. Should no support be forthcoming, the Company would cease to trade. The activities of the Company result from mainly non-cash accounting transactions with the ultimate parent undertaking and the Company is not self-sustaining due to the lack of trading activities to support it's continued existence. On this basis, the directors consider it appropriate to prepare the financial statements on the going concern basis. Given the above, the directors have concluded that there is a material uncertainty which may cast significant doubt to the Company's ability to continue as a going concern and therefore it may be unable to realise it's assets and discharge it's liabilities in the normal course of business.
Name history
Renamed 1 time since incorporation
- MSCP HOLDINGS LIMITED 2015-06-03 → present
- THE HEALTH CLUB COLLECTION LIMITED 2012-09-07 → 2015-06-03
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£86,127 | -£98,116 | |
| Profit before tax | -£86,127 | -£98,116 | |
| Net profit | -£86,127 | -£98,116 | |
| Cash | — | — | |
| Total assets less current liabilities | £186,797 | £88,681 | |
| Net assets | £186,797 | £88,681 | |
| Equity | £186,797 | £88,681 | |
| Average employees | — | — | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | -46.1% | -110.6% | |
| Gearing (liabilities / total assets) | 86.8% | 93.8% | |
| Current ratio | 0.00x | 0.00x | |
| Interest cover | -1.00x | -1.00x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“At the time of approving the financial statements, the directors considered the financial position of the Company as a non trading entity and their accompanying risks, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future, being at least 12 months from the approval of the Annual report and financial statements, however, the Company is in a net current liability position of £1,331,319 as at 31 December 2024, primarily consisting of amounts owed to the group undertakings. The directors understand that Nuffield Health will not demand repayment of the £1,330,879 balance due to group undertakings. However, the directors have not received a binding commitment that this support will be forthcoming in the future. Nevertheless the directors are of the view that the ultimate controlling parent undertaking will ensure that sufficient funds are available to settle any liabilities when they fall due. Should no support be forthcoming, the Company would cease to trade. The activities of the Company result from mainly non-cash accounting transactions with the ultimate parent undertaking and the Company is not self-sustaining due to the lack of trading activities to support it's continued existence. On this basis, the directors consider it appropriate to prepare the financial statements on the going concern basis. Given the above, the directors have concluded that there is a material uncertainty which may cast significant doubt to the Company's ability to continue as a going concern and therefore it may be unable to realise it's assets and discharge it's liabilities in the normal course of business.”
Group structure
- MSCP HOLDINGS LIMITED · parent
- MSCP Wellbeing Limited 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 16 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| THOMSON, Iben | Secretary | 2022-11-30 | — | — |
| BAKER, Paul Martin | Director | 2025-12-10 | Jun 1969 | British |
| THOMSON, Iben Charlotte | Director | 2024-08-20 | May 1968 | British |
Show 16 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| NEWMAN, Toby | Secretary | 2017-02-28 | 2022-11-30 |
| TALBUTT, Luke | Secretary | 2015-06-02 | 2017-02-28 |
| INTERNATIONAL REGISTRARS LIMITED | Corporate Secretary | 2012-09-07 | 2015-06-02 |
| BLACKWELL-FROST, Chris | Director | 2017-10-31 | 2022-11-30 |
| BURTON, Gary Lee | Director | 2016-05-31 | 2018-09-21 |
| DILLON, Jennifer Ann | Director | 2018-09-21 | 2022-11-30 |
| FARRELL, Derrick Michael | Director | 2015-06-02 | 2016-05-31 |
| HYATT, Greg | Director | 2015-06-02 | 2017-10-31 |
| LAMBERT, Amanda | Director | 2022-11-30 | 2024-10-31 |
| LYNN, Matthew | Director | 2024-08-01 | 2025-12-10 |
| SEFTON, Alan Charles | Director | 2014-10-15 | 2015-06-02 |
| SMITH, Caroline Naomi | Director | 2022-11-30 | 2024-09-03 |
| TAYLOR, Jeremy Guy | Director | 2012-09-07 | 2015-06-02 |
| TURNER, Aron | Director | 2012-09-07 | 2015-06-02 |
| TURNER, David | Director | 2012-09-07 | 2015-06-02 |
| WENBOURNE, Stewart James | Director | 2012-09-07 | 2015-06-02 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Nuffield Health | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 68 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-11 | AP01 | officers | Appoint person director company with name date | |
| 2025-12-11 | TM01 | officers | Termination director company with name termination date | |
| 2025-09-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-28 | AA | accounts | Accounts with accounts type full | |
| 2024-11-04 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-04 | AA | accounts | Accounts with accounts type full | |
| 2024-09-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-03 | TM01 | officers | Termination director company with name termination date | |
| 2024-09-03 | CH01 | officers | Change person director company with change date | |
| 2024-08-29 | AP01 | officers | Appoint person director company with name date | |
| 2024-08-02 | AP01 | officers | Appoint person director company with name date | |
| 2023-09-20 | AA | accounts | Accounts with accounts type full | |
| 2023-09-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-12-01 | TM01 | officers | Termination director company with name termination date | |
| 2022-12-01 | TM01 | officers | Termination director company with name termination date | |
| 2022-12-01 | AP01 | officers | Appoint person director company with name date | |
| 2022-12-01 | AP01 | officers | Appoint person director company with name date | |
| 2022-12-01 | AP03 | officers | Appoint person secretary company with name date | |
| 2022-12-01 | TM02 | officers | Termination secretary company with name termination date | |
| 2022-11-17 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
—
Not reported
-
Net assets
-52.5%
£186,797 £88,681
-
Employees
—
Not reported
-
Operating profit
-13.9%
-£86,127 -£98,116
-
Profit before tax
-13.9%
-£86,127 -£98,116
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers